AC22 - Session III :: Targeted Therapies and Overcoming Resistance

Overcoming resistance to immunotherapyПодробнее

Overcoming the challenge of resistance to targeted therapies in CLLПодробнее

Webinar: Lung Cancer Clinical Trials Evaluating Efficacy and Overcoming Resistance | VeedaПодробнее

Targeted Therapy Resistance Mechanisms in ALK+ NSCLCПодробнее

Overcoming Resistance in ER+ Breast CancerПодробнее

Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in MelanomaПодробнее

Strategies to overcome resistance to targeted therapies in colorectal cancerПодробнее

Overcoming acquired resistance to targeted therapy in colorectal cancerПодробнее

Dr. Jeffrey Weitzel on Overcoming Resistance With Combination TherapyПодробнее

2018 NAM Annual Meeting - Overcoming Resistance to Molecularly Targeted Cancer TherapyПодробнее

Optimizing and overcoming resistance to current KRAS inhibitorsПодробнее

Lung Cancer — Overcoming Drug ResistanceПодробнее

Overcoming Resistance to PARP Inhibitors in Ovarian CancerПодробнее

ALK TKI Side Effects and Acquired Resistance - 2022 Program: Targeted Therapies ForumПодробнее

Dr. Hamilton on Overcoming Resistance to HER2-Targeted Therapy in Breast CancerПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

Acquired resistance to anti-EGFR therapy in colorectal cancerПодробнее

Chemical Biology Approach to Understanding and Overcoming Resistance of Cancers to TreatmentsПодробнее

Targeting Treatment-Resistant Mutations using "Off Target" Targeted TherapiesПодробнее